Managing Diabetes in Pregnancy  

How do we approach diabetes management during pregnancy?Our host, Dr. Ronald Goldenberg, takes a deeper look into this topic with Dr. Denice Feig, an Endocrinologist, diabetes researcher, and champion for women’s health. She is Head of the Diabetes in Pregnancy Program at Mount Sinai Hospital and an Associate Professor at the University of Toronto’s Department of Medicine. Dr. Feig’s work aims to improve the standard of care for pregnant women with pre-existing and gestational diabetes.This episode discusses the topics of glycemic targets throughout pregnancy, taking second-generation basal analogues during pregnancy, and the use of continuous glucose monitoring (CGM) to improve outcomes for pregnant women with diabetes. Our experts also discuss Dr. Feig’s research investigating whether the use of CGM in women with type 1 diabetes can improve glycemic control compared to standard capillary blood glucose monitoring.Don’t miss the conversation!The views and opinions expressed in this episode are those of the speakers and do not necessarily reflect the views or positions of any entities they represent.Declaration of conflict of interest:Dr. Goldenberg:Direct financial relationship including receipt of honoraria: Abbott, Agora, Amgen, Antibody, AstraZeneca, Bayer, Boehringer Ingelheim, CCRN, CMSKTRG, Eli Lilly, EOCI, HIT Global, HLS, Inceptus, Janssen, LiV, Master Clinician Alliance, MD Briefcase, Merck, Mylan, Novo Nordisk, Sanofi, Script Medical, Servier, STA, Takeda, Toronto Knowledge Translation Working Group, Unik, Valeant. Membership on advisory boards or speaker’s bureau: Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, HLS, Janssen, Merck, Novo Nordisk, Sanofi. Funded grants, research or clinical trials: Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Sanofi.Dr. Feig:Direct financial relationship including receipt of honoraria: Sanofi. Membership on advisory boards or speaker’s bureau: Novo Nordisc. Funded grants, research or clinical trials: CIHR, JDRF.